0000000000654362
AUTHOR
Emilia Scalzulli
showing 2 related works from this author
Low-dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
2020
A multicenter real‐life study on anticoagulant treatment with direct oral anticoagulants in patients with P h‐negative myeloproliferative neoplasms
2020
NA